Enovis to Present at the Canaccord Genuity Musculoskeletal Conference on Monday, February 12, 2024
07 Février 2024 - 10:15PM
Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical
technology growth company, today announced that Brady Shirley,
President and COO, Ben Berry, CFO, and Louis Vogt, Group
President Recon will present at the Canaccord Genuity
Musculoskeletal Conference. The presentation is scheduled to begin
at 5:30pm p.m. ET (2:30 p.m. PT) on Monday, February
12, 2024.
A link to the live audio webcast, as well as a
replay of this event, will be available on the company’s website at
Events and Presentations.
ABOUT ENOVIS
Enovis Corporation (NYSE: ENOV) is an
innovation-driven medical technology growth company dedicated to
developing clinically differentiated solutions that generate
measurably better patient outcomes and transform workflows. Powered
by a culture of continuous improvement, global talent and
innovation, the Company’s extensive range of products, services and
integrated technologies fuels active lifestyles in orthopedics and
beyond. The Company’s shares of common stock are listed in the
United States on the New York Stock Exchange under the symbol
ENOV. For more information about Enovis, please
visit www.enovis.com.
Contact:
Kyle RoseVice President, Investor RelationsEnovis
Corporation+1-917-734-7450investorrelations@enovis.com
Enovis (NYSE:ENOV)
Graphique Historique de l'Action
De Août 2024 à Sept 2024
Enovis (NYSE:ENOV)
Graphique Historique de l'Action
De Sept 2023 à Sept 2024